Related Experiment Video
Updated: Jun 6, 2025
07:54
Drug-Induced Sleep Endoscopy DISE with Target Controlled Infusion TCI and Bispectral Analysis in Obstructive Sleep Apnea
Published on: December 6, 2016
19.7K
The Emerging Role of Pharmacotherapy in Obstructive Sleep Apnea
Nikhil Jaganathan1, Younghoon Kwon2, William J Healy3
1Medical College of Georgia, Augusta University, Augusta, GA 30912, USA.
Journal of Otorhinolaryngology, Hearing and Balance Medicine
|November 26, 2024
Summary
New drug classes show promise for treating obstructive sleep apnea (OSA). Respiratory stimulants and GLP-1 receptor agonists may offer effective alternatives to CPAP for managing this common sleep disorder.
Area of Science:
- Pulmonology
- Pharmacology
- Sleep Medicine
Background:
- Obstructive sleep apnea (OSA) is a widespread condition with limited treatment tolerance.
- Continuous positive airway pressure (CPAP) is the standard, but alternatives are needed due to side effects.
- Pharmacotherapy presents a potential avenue for OSA management.
Purpose of the Study:
- To review emerging pharmacologic treatments for obstructive sleep apnea.
- To explore the mechanisms and efficacy of respiratory stimulants and GLP-1 receptor agonists.
- To discuss the future potential of these drug classes in OSA treatment.
Main Methods:
- Narrative review of existing literature on pharmacologic agents for OSA.
- Analysis of preliminary studies on noradrenergic-antimuscarinic combinations and GLP-1RAs.
- Discussion of drug mechanisms, current data, and future prospects.
Main Results:
- Noradrenergic-antimuscarinic combinations show potential by stimulating airway muscles and reducing apnea-hypopnea index (AHI).
- Glucagon-like peptide 1 receptor agonists (GLP-1RAs) demonstrate efficacy through weight loss and AHI reduction.
- Preliminary data suggest significant improvements in AHI and oxygen saturation with these agents.
Conclusions:
- Pharmacotherapy, including respiratory stimulants and GLP-1RAs, offers promising alternatives for OSA treatment.
- These agents may improve airway patency and reduce OSA severity.
- Further research is warranted to establish the long-term efficacy and safety of these novel treatments.
More Related Videos
Related Concept Videos
01:21Sleep Apnea
128
Sleep apnea is a condition where breathing stops intermittently during sleep, often leading to significant health issues. Each episode can last from 10 to 20 seconds or more and is frequently accompanied by a brief arousal from sleep. This disturbance, largely unnoticed by the individual, can lead to severe daytime fatigue. Commonly, individuals seek help after being informed by their partners about loud snoring and noticeable breathing pauses during sleep.
The condition is more prevalent among...
The condition is more prevalent among...
128
01:19Management of Insomnia
231
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
231
01:28Drug Therapy
39
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
39
01:16Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
172
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
172
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
146
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
146
01:29Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K